GLP-1 Patients Regain Most of Their Lost Weight Within 2 Years . A Tampa Telehealth Provider Is Partnering With a Digital Health Platform to Change That.
As prescriptions for semaglutide and tirzepatide surge nationwide, a growing body of research shows that medication alone rarely produces lasting weight loss. Precision Telemed and Monj Health are launching the Advanced Metabolic Program to address what clinicians have started calling the missing piece in GLP-1 care.
United States, 12th Jun 2026 – GLP-1 medications such as compounded semaglutide and tirzepatide have changed what is possible in weight loss care. For the first time in decades, patients are seeing reductions of 15 to 20 percent of body weight, with improvements in blood sugar, blood pressure, and cardiovascular markers that were once reserved for surgery.
There is, however, a quieter problem unfolding behind those headlines. Roughly half of patients stop GLP-1 therapy within...
